IEX •
Healthcare •
Medical Devices •
Quote as of 07/01/2026 15:59
Company Profile
IndustryMedical Devices
SectorHealthcare
ExchangeIEX
Market Capitalization749.53 mln
Float25.34 mln
Earnings Date08/04/2026
Beneish M-Score
-2.4
Borderline
1-Year Forecast
19.18
Modest upside
Relative Strength
95
/ 100
Top performer
Debt / Equity
0.03
Debt-free
ROE
-22.61
Deeply negative
Dividend Yield
0.00%
No dividend
Business Description
Beta Bionics makes medical devices that help people with diabetes manage their insulin automatically. Its main product, the iLet Bionic Pancreas, handles insulin delivery on its own for adults and children as young as six, removing much of the daily burden of managing type 1 diabetes. The company is working on several next-generation products, including a tubeless patch pump and a device that delivers both insulin and glucagon together. Founded in 2015 and based in Irvine, California, Beta Bionics works alongside Abbott Diabetes Care and Xeris Pharmaceuticals to bring these solutions to market.
